02256 ABBISKO-B
- 4.550
- -0.150-3.19%
ABBISKO-B News
ABBISKO-B: VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS PRESENTED RESULTS ON MODEL-INFORMED DOSE SELECTION FOR PIMICOTINIB AT ACOP 2024
ABBISKO-B: INSIDE INFORMATION - POSITIVE TOP-LINE RESULTS FROM PIVOTAL PHASE 3MANEUVER STUDY OF PIMICOTINIB IN TGCT PATIENTS ANDUPDATED RESULTS FROM PHASE 1 STUDY OFPIMICOTINIB IN TGCT PATIENTS
ABBISKO-B: VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS TO PRESENT PRELIMINARY PHASE 2 STUDYRESULTS OF PIMICOTINIB FOR THE TREATMENTOF CGVHD AT THE 66TH ASH ANNUAL CONFERENCE
ABBISKO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
ABBISKO-B: VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS PRESENTED PRECLINICAL RESEARCH RESULTS OF ITS PRMT5*MTA AND ORAL KRASG12D PROGRAMS AT THE EORTC-NCI-AACR CONFERENCE
ABBISKO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
ABBISKO-B: Next Day Disclosure Return - Changes in Issued Share Capital
ABBISKO-B: VOLUNTARY ANNOUNCEMENT - ON-MARKET SHARE REPURCHASE AND REPURCHASED SHARES CANCELLATION
ABBISKO-B: VOLUNTARY ANNOUNCEMENT - ABK3376 OBTAINED IND APPROVAL FROM NMPA
ABBISKO-B: 2024 INTERIM REPORT
ABBISKO-B: VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS PRESENTS UPDATED CLINICALPROGRESS ON IRPAGRATINIB AND PIMICOTINIBAT ESMO CONGRESS
ABBISKO-B: Next Day Disclosure Returns
ABBISKO-B: Next Day Disclosure Returns
ABBISKO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
ABBISKO-B: Next Day Disclosure Returns
ABBISKO-B: Next Day Disclosure Returns
ABBISKO-B: Next Day Disclosure Returns
ABBISKO-B: Next Day Disclosure Returns
ABBISKO-B: Next Day Disclosure Returns
ABBISKO-B: Next Day Disclosure Returns
Analysis
Price Target
No Data
No Data